MedTrace Logo

Study of Intramuscular Ropivacaine Injections for Treatment of Pediatric Headache

NCT00680823 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2018-02-26

Study results available
· View outcomes & findings →

Summary

Objective: To determine if lower paracervical intramuscular ropivacaine injection is an effective treatment for pediatric headache in an emergency department setting.

Conditions

Interventions

DRUG

Ropivacaine

1.5 mL IM to each side in to the lower cervical paraspinous muscles x 1.

DRUG

Normal saline

1.5 mL IM to each side in to the lower cervical paraspinous muscles x 1.

Sponsors & Collaborators

  • Robert Hickey

    lead OTHER

Principal Investigators

  • Susan Sieminski, MD · University of Pittsburgh

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
7 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00680823 on ClinicalTrials.gov